What is BYETTA?
BYETTA is an injectable prescription medicine used to improve blood sugar (glucose) levels in adults with type 2 diabetes. According to the manufacturer, BYETTA was the first glucagon-like peptide-1 (GLP-1) receptor agonist to be approved by the FDA for the treatment of type 2 diabetes. BYETTA works in conjunction with the stomach, liver, pancreas, and brain to improve blood sugar levels, similar to the human incretin hormone GLP-1. BYETTA can be used with metformin, a sulfonylurea, a thiazolidinedione or Lantus® (insulin glargine).It was approved for use in the United States in 2005 and has been used by almost 2 million diabetic patients since its introduction. For best results BYETTA should be used in conjunction with lifestyle changes such as improved diet and increased exercise, but it should not be used as a substitute for insulin.